EPRX Eupraxia Pharmaceuticals Inc
- 4.340
- +0.040+0.93%
Eupraxia Pharmaceuticals Inc News
Eupraxia Pharmaceuticals Inc: REPORT OF EXEMPT DISTRIBUTION NI 45106
Eupraxia Pharmaceuticals Inc: PROSPECTUS NON PRICING SUPPLEMENT OTHER THAN ATM EN
Eupraxia Pharmaceuticals Inc: UNDERWRITING OR AGENCY AGREEMENTS OR AMENDMENT THERETO
Eupraxia Pharmaceuticals Inc: CONSENT LETTER OF ISSUERS LEGAL COUNSEL
Eupraxia Pharmaceuticals Inc: CONSENT LETTER OF UNDERWRITERS LEGAL COUNSEL
Eupraxia Pharmaceuticals Inc: UNDERTAKING RE NOVEL DERIVATIVES OR ASSETBACKED SECURITIES
Eupraxia Pharmaceuticals Inc: UNDERTAKING RE BREAKDOWN OF SALES AND PAYMENT OF FEES BC
Eupraxia Pharmaceuticals Inc: CONSENT LETTER OF ISSUERS LEGAL COUNSEL
Eupraxia Pharmaceuticals Inc: NONISSUERS SUBMISSION TO JURISDICTION AND APPOINTMENT OF AGENT
Eupraxia Pharmaceuticals Inc: OTHER UNDERTAKINGS
Eupraxia Pharmaceuticals Inc: AUDITORS CONSENT LETTER
Eupraxia Pharmaceuticals Inc: FINAL SHORT FORM PROSPECTUS EN
Eupraxia Pharmaceuticals Inc: AMENDMENT TO OR AMENDED PRELIMINARY SHORT FORM PROSPECTUS EN
Eupraxia Pharmaceuticals Inc: QUALIFICATION CERTIFICATE
Eupraxia Pharmaceuticals Inc: PRELIMINARY SHORT FORM PROSPECTUS EN
Eupraxia Pharmaceuticals Inc: REPORT OF EXEMPT DISTRIBUTION NI 45106
Eupraxia Pharmaceuticals Inc: CONSENT LETTER OF ISSUER'S LEGAL COUNSEL
Eupraxia Pharmaceuticals Inc: AUDITORS' CONSENT LETTER
Eupraxia Pharmaceuticals Inc: NON-ISSUER'S SUBMISSION TO JURISDICTION AND APPOINTMENT OF AGENT
Eupraxia Pharmaceuticals Inc: FINAL SHORT FORM PROSPECTUS - ENGLISH
No Data